Antibacterial activity of rifaximin against Clostridium difficile, Campylobacter jejunii and Yersinia spp.
Mignini
F
F
Department of Cellular Biology, Chair of Microbiology, Faculty of Pharmacy, University of Camerino, Italy.
Falcioni
E
E
Prenna
M
M
Santacroce
F
F
Ripa
S
S
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D016123:Campylobacter jejuni / Q000187:drug effects* / Q000302:isolation & purification; D016360:Clostridioides difficile / Q000187:drug effects* / Q000302:isolation & purification; D006801:Humans; D008826:Microbial Sensitivity Tests; D012294:Rifamycins / Q000494:pharmacology*; D000078262:Rifaximin; D015007:Yersinia / Q000187:drug effects* / Q000302:isolation & purification
D000900:Anti-Bacterial Agents; D012294:Rifamycins; D000078262:Rifaximin